| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |